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ABSTRACT
Background: A number of recent studies has demon-
strated a critical role for mast cells and mast
cell-derived cytokines, especially tumour necrosis
factor (TNF), in the control of host defense mecha-
nisms during inflammation. In the presesnt study, 
we investigated whether TNF-deficient (TNF–/–) and
granulocyte–macrophage colony stimulating factor
(GM-CSF)-deficient (GM-CSF–/–) mice expressed defects
in normal mast cell function.
Methods: Because the first step in the passive cuta-
neous anaphylactic (PCA) reaction is fixation of the
antibody to mast cells, we tried to obtain a PCA in
TNF–/– and GM-CSF–/– mice.
Results: While an anti-dinitrophenyl IgE monoclonal
antibody induced a strong PCA reaction in wild-type
mice, it was not possible to obtain a PCA reaction in
either TNF–/– or GM-CSF–/– mice. We next examined
whether mast cells were present in these mice and if
so, did they have functional FcεRI receptors on their
surface. The number of mast cells in smears from the
peritoneal fluid of the TNF–/– and GM-CSF–/– mice was
similar to that seen in wild-type mice. However, the
expression of FcεRI on mast cells from the peritoneal
fluid of TNF–/– and GM-CSF–/– mice, measured by
either rosetting assay or FACScan analysis, was com-
promised compared with wild-type mice. Previous
studies have established that defects in FCεRI expres-
sion often have found that IgE production was com-
promised in both TNF–/– and GM-CSF–/– mice.
Conclusions: The observed defects may partially
explain the immunodeficiency of these cytokine-deficient
animals during infection.
Key words: granulocyte–macrophage colony stimu-
lating factor-deficient mice, IgE, mast cell, passive
cutaneous anaphylactic reaction, tumor necrosis factor-
deficient mice.
INTRODUCTION
Mast cells are derived from pluripotent cells of the bone
marrow. Mast cell development in the mouse has been
shown to be dependent on the cytokines interleukin (IL)-3
and IL-4, wherease granulocyte–macrophage colony
stimulating factor (GM-CSF) appears to inhibit mast cell
proliferation.1 Recent studies point towards an unex-
pected but critical role for mast cells in resistance to
infections2,3 and these studies implicate a mast cell-
derived cytokine, namely tumor necrosis factor (TNF), as
a central element in this mast cell function.2,3 However,
the role of GM-CSF and TNF in mast cell function is still
not established.
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The most important role for mast cells has long been
recognized as the effector cells of the immediate-type
hypersensitivity reactions.4 To examine the role of GM-
CSF and TNF in the development and expression of
mast cell effector function, we tested mice deficient for
these factors. We report herein that mast cell function 




The generation of TNF–/– and GM-CSF–/– mice on the
C57BL/6 × 129 background has been described pre-
viously.5,6 Wild-type littermates, from the mating of
heterozygous (TNF+/–) mice were used as controls.
BALB/c and C3H-scid/scid7 mice were obtained from the
Jackson Laboratory (Bar Harbor, ME, USA). Mice were
housed in a specific pathogen-free environment and
were tested monthly to confirm their pathogen-free status.
Experiments were performed on male 8–10-week-old
mice in accordance with protocols approved by the
New York University Institutional Animal Care and Use
Committee.
Materials
Histamine dihydrochloride was obtained from Sigma
Chemical Co. (St Louis, MO, USA) and was diluted in
saline to 1 µg/mL. Heparin ammonium salt (Sigma
Chemical Co.) was diluted in saline to 25 µg/mL for
i.p. injections. Evans blue dye (Eastman Kodak, Rochester,
NY, USA) was diluted in saline to 1%. Bisdiazotized ben-
zidine (BDB) was prepared using a benzidine base
(Eastman Kodak).8 Aliquots of 0.5 mL BDB were stored at
–70°C until use. Peroxidase-labeled avidin was obtained
from Dako (Carpinteria, CA, USA) and bovine serum
albumin (BSA) was from Armour (Kankakee, IL, USA).
Sheep erythrocytes (SE) were from Colorado Serum
(Denver, CO, USA). The preparation of dinitrophenylated
proteins has been described elsewhere.9,10 We used
DNP25 BSA and DNP13KLH (Keyhole limpet hemo-
cyanin (KLH)). The numbers are per one molecule 
of protein for BSA and for 100 000 MW for KLH. 
The generation of monoclonal anti-dinitrophenyl (DNP) 
IgE, B53 (passive cutaneous anaphylactic (PCA) reaction
titer 1/16 000)11 and rat monoclonal antimurine IgE
antibody (HMK-12)12 have been described elsewhere.
The hybridoma cell line SPE7, derived from murine
C57BL/6 cells, secreting monoclonal anti-DNP IgEb, was
a generous gift from Dr Z Eshhar (Weizmann Institute,
Rehovot, Israel). It was maintained in the Department 
of Rheumatology, Juntendo University, Medical School,
Tokyo, Japan. The fluorescein isothiocyanate (FITC)-
labeled SPE-7 was prepared using standard methods
according to the manufacturer’s instructions (Phar Mingen,
San Diego, CA, USA). Antibody determinations were by
ELISA as described elsewhere.12,13
Passive cutaneous anaphylactic reactions
Mice were manipulated under light ketamine anesthesia.
This precaution is necessary because even minimal bruis-
ing may provoke an increase in the permeability of small
venules. The dorsal skin of the mouse was shaved and
injected intradermally with 0.05 mL of dilutions of B53.
Four hours later, in other spots, saline (negative con-
trol) or histamine (positive control) were injected intra-
dermally. Immediately after the intradermal injections of
saline and histamine, animals were injected intravenously
with 0.2 mL antigen and dye, a mixture in equal volume
of 1% Evans blue in saline and 10 mg/mL DNP25BSA in
saline. We also examined the PCA reaction using anti-
DNP-IgG1 and antibody instead of B53. The reactions
were read 20 min later and scored.14 To confirm that
mast cell numbers in the skin of mutant mice were similar
to those in wild-type mice, samples of dorsal skin were
harvested and mast cell numbers were quantitated. Skin
samples were rolled, fixed in 10% buffered formalin and
paraffin embedded in a vertical orientation. Sections
were stained by Giemsa and 15 40× microscopic fields
were analyzed for the prevalence of mast cells.
Mast cell isolation
Mast cells were obtained from the peritoneal cavity of
mice as described elsewhere.9,10 Briefly, 2 mL heparin 
(5 mg/mL) in saline was injected i.p. and the abdomen
was then gently massaged for 2 min. Mice were killed by
CO2 asphyxiation and the contents of the peritoneal
lavage was layered onto a gradient of BSA in Ringer’s
solution composed of 1 mL of 28% BSA over 1 mL of
35% BSA. The tube was centrifuged in a swinging head
rotor at 270 g for 6 min at 4°C. The top layer and the
upper half of the middle layer were removed and dis-
carded and 3 mL Ringer’s solution was added to the
remaining material. The tube was then centrifuged at
250 g for 6 min. The cells in the bottom layer (enriched
164 M YAMADA ET AL.
mast cells), were washed and resuspended in 3 mL
Ringer’s solution for further experiments. Mast cell purity
in these preparations ranged from 30 to 60%. For any
one experiment, cells from all mice were prepared in par-
allel and the number of mast cells between preparations
varied by approximately 10%.
Rosette formation
The DNP25BSA was prepared as described previously.9
Briefly, a 0.05 mL volume of packed washed SE was
added to a tube containing 1.6 mL saline, 3.5 mL of
0.11 mol/L phosphate buffer (pH 7.4) and 2.0 mL of a
500 µg/mL solution of DNP25BSA in saline. To 0.5 mL
frozen BDB, 3.5 mL chilled phosphate-buffered saline
was added and 0.5 mL of this solution was immediately
added to the SE suspension, mixed well and allowed to
react at room temperature for 10 min with occasional
mixing. The coated SE were centrifuged at 500 g for 
5 min, washed once with phosphate buffer and once
with saline before being resuspended in saline to a con-
centration of 1% (volume). These DNP25BSA-coated
SE (DNP-SE) showed a minimal tendency either to agglu-
tinate spontaneously or to form non-specific rosettes
around normal mast cells.
A 1 mL sample of the 1% DNP-SE solution was mixed
with 1 mL of a 1/10 dilution in saline of B53, kept at
room temperature for 90 min with frequent swirling, then
centrifuged at 250 g for 5 min, washed twice with saline
and finally suspended in 1 mL saline. This preparation
was used to examine rosette formation with mast cell-
enriched peritoneal cells.
A sample of 0.05 mL enriched mast cell suspension
and 0.05 mL B53-fixed DNP-SE suspension (see above)
was incubated for 30 min with frequent gentle mixing at
room temperature and examined following the addition
of 0.01 mL of 0.1% Toluidine blue by microscope in a
counting chamber.
FACScan examination
To measure expression of FcεR1, we used FITC-labeled
monomeric IgE, which binds preferentially to this high-
affinity receptor.13 A small aliquot (0.05 mL) of the
enriched mast cell preparation was incubated with
0.05 mL FITC-labeled SPE-7 (10 µg/mL final dilution)
for 1 h at 4°C, followed by centrifugation for 5 min at
250 g, washed twice and analyzed on a FACScan
(Becton Dickinson, San Diego, CA, USA).
IgE production
Eight-week-old mice, were injected i.p. with 10 µg
DNP13KLH and 4 mg aluminum hydroxide. Mice were
re-injected i.p. with the same amount of this mixture 
2 weeks later. Serum was obtained on days 14, 21 and
28 after the primary immunization for anti-DNP IgE deter-
mination by ELISA.12,13
RESULTS
Passive cutaneous anaphylactic reactions
Passive cutaneous anaphylactic reactions obtained in
BALB/c, wild-type, GM-CSF–/–, TNF–/– and SCID mice
are given in Table 1. Analysis of the prevalence of mast
cells in dorsal skin indicated no reduction in mast cell
numbers in any of the mutant mice compared with wild-
type mice. (The number of mast cells harvested from the
dorsal skin dermis of each strain was as follows: BALB/c,
12.6 ± 1.6 × 104 /mm2; wild type 9.8 ± 1.1 × 104 /mm2;
GM-CSF–/–, 9.5 ± 1.2 × 104 /mm2; TNF–/–, 10.7 ± 1.9 ×
104 /mm2; SCID, 11.3 ± 1.4 × 104 /mm2.) None of the
mice reacted to injection of saline (negative control) and
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Table 1 Passive cutaneous anaphylaxis in wild-type and granulocyte–macrophage colony stimulating factor –/– and tumor 
necrosis factor –/– mice
Injection Mouse strain
BALB/c Wild type GM-CSF –/– TNF –/– SCID
Saline – – – – –
Histamine (1 µg/mL) + + + + +
B53 1/4000 ++ + – – –
B53 1/8000 + + – – –
IgG1 1/1000 + + – – ND
Dilutions of anti-DNP IgE monoclonal antibody (B53) or anti-DNP IgG1, IgG2a were injected intradermally 4 h before challenge, while histamine
and saline were injected just before challenge with 1 mg DNP25BSA in 0.5% Evans blue dye in saline. Reactions were read 20 min after challenge.
–, no reaction; +, reactions between 10 and 15 mm; ++, reactions greater than 15 mm.
all reacted to intradermal injection of histamine (positive
control). The threshold reaction in BALB/c and wild-type
mice was obtained with a dilution of 1/8000 anti-DNP
B53 antibody. As shown in Table 1, no reaction was
obtained with a 1/4000 dilution of B53 in GM-CSF–/–,
TNF–/– or SCID mice. Even with a 1/100 dilution of 
B53, we did not obtain any reactions in GM-CSF–/–,
TNF–/– or in SCID mice. The 1/1000 dilution of IgG1,
which was able to produce a PCA reaction in wild-type
mice was unable to induce a PCA reaction in GM-
CSF–/– or TNF–/– mice.
Rosette formation with IgE-coated DNP-SE
Examination of mast cell-enriched peritoneal cell prep-
arations after staining with Wright–Giemsa showed
approximately equal numbers of mast cells in wild-type,
TNF–/–, GM-CSF–/– and SCID mice. (The number of mast
cells isolated from the peritoneal cavity of each strain was
as follows: BALB/c, 4.2 ± 1.0 × 104 /mouse; wild type,
4.1 ± 0.6 × 104 /mouse; TNF–/–, 3.9 ± 0.8 × 104 /mouse
GM-CSF–/–, 3.7 ± 0.5 × 104 /mouse; SCID–, 4.6 ± 0.4 ×
104 /mouse). Next, we examined fresh preparations of
these peritoneal mast cell-enriched peritoneal fluid
samples admixed with an equal volume of DNP25BSA
and IgE (B53)-coated sheep erythrocytes in a rosetting
assay. In the present study, a rosette was defined as only
those nucleated cells around which at least four erythro-
cytes were found. We counted at least 100 rosettes on a
slide covered with mast cell-enriched peritoneal fluid
from BALB/c or wild-type mice, but we did not find any
rosettes when peritoneal cells were taken from GM-
CSF–/–, TNF–/– or SCID mice (Fig. 1).
FACScan examination
The FACScan (Fig. 2) examination of the mast cell-
enriched peritoneal cells incubated with the FITC-labeled
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Fig. 1 Rosette formation of peritoneal mast cells with DMP25BSA-labeled sheep erythrocytes coated with anti-dinitrophenyl
(DNP) IgE. A 0.050 mL sample of washed mast cell preparations was mixed with 0.05 mL of a 1/100 suspension of DNP25BSA
and anti-DNP-coated sheep erythrocytes (see Methods). (a) Wild-type mice, (b) tumor necrosis factor (TNF)–/– mice, (c) granulocyte–
macrophage colony stimulating factor (GM-CSF)–/– mice and (d) SCID mice.
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murine monoclonal IgE (SPE-7) from both GM-CSF–/–
and TNF–/– mice showed a very similar image and dif-
fered from that of wild-type mice. The image seen for
mast cell-enriched peritoneal cells from wild-type mice
treated with the same FITC-labeled monoclonal IgEb was
shifted to the right and had a shoulder.
IgE production
Anti-DNP IgE antibody production in wild-type, GM-
CSF–/– and TNF–/– mice is shown in Fig. 3. None of 
the mice produced much anti-DNP IgE antibody after
primary immunization at day 14. However, at days 21
and 28 (7 and 14 days after boost injections) significantly
less antibody was produced in both GM-CSF–/– and
TNF–/– mice compared with wild-type controls.
Fig. 3 IgE antibody production. Anti-dinitrophenyl (DNP)
antibody production in wild-type, tumor necrosis factor (TNF)–/–
and granulocyte–macrophage colony stimulating factor (GM-
CSF)–/– mice. Data are mean (±SD) serum anti-DNP13KLH
levels (ng/mL) in three mice measured at day 14 (), 21 ( )
and 28 ( ) after immunization.
Fig. 2 FACScan analysis of FCεR1 expression of peritoneal mast cells. A sample of 1 × 105 mast cell-enriched peritoneal cells was
suspended in 50 µL staining buffer, to which 5 µg fluorescein isothiocyanate-labeled SPE-7 in 50 µL staining buffer was added, and
this mixture was incubated for 1 h at 4°C with occasional mixing, then washed three times with phosphate-buffered saline and exam-
ined by flow cytometry. (a) Wild-type mice, (b) granulocyte–macrophage colony stimulating factor (GM-CSF)–/– mice, (c) tumor
necrosis factor (TNF)–/– mice.
DISCUSSION
In the present study, we demonstrated that: (i) we could
not get a PCA reaction in TNF–/–, GM-CSF–/– and in
SCID mice; (ii) we could not see rosettes on peritoneal
mast cells incubated with anti-DNP IgE-labeled SE; and
(iii) FACScan analysis confirmed these rosetting assays.
We also showed that GM-CSF–/– and TNF–/–mice differ
from wild-type mice in the production of IgE antibody
when immunized with the DNP13KLH at either 21 or 
28 days. The anti-DNP IgE production is much less 
in both the GM-CSF–/– and TNF–/– strains than in wild-
type mice.
We examined whether GM-CSF–/–, TNF–/– and SCID
mice could be sensitized with murine IgE antibodies to
produce anaphylactic reactions. The PCA reaction elimi-
nates the problem of antibody production, a significant
concern in TNF- and GM-CSF-deficient mice, both of
which have been shown to exhibit defects in antibody
production.5,15–17 Although the number of mast cells har-
vested from the dorsal skin dermis of each strain was not
significantly different, the PCA reaction of both TNF–/–
and GM-CSF–/– mice was compromised similar to SCID
mice, which have been shown, using a different model,18
to have a defective anaphylactic response.
It is well known that the first step of such anaphylactic
reactions is mainly the bridging of two IgE molecules fixed
on mast cells19 mediated by binding through the Fc
domain.20 Mast cells normally possess on their surface
the high-affinity receptors for IgE (FcεRI), a complex mul-
timolecular structure.21–23 Mast cells from wild-type mice
are expected to express FcεRI molecule on their cell
surface. Therefore, we examined whether the FCεRI is
present or absent on the surface of mast cells of wild-
type, GM-CSF–/–, TNF–/– or SCID mice by direct examin-
ation of peritoneal mast cells with SE coupled to a DNP
protein and covered with a monoclonal anti-DNP IgE
antibody. The number of peritoneal mast cells in TNF–/–
and GM-CSF–/– mice was not significantly different com-
pared with wild-type mice. However, in the case of rosette
formations, many mast cell rosettes were found in peri-
toneal cells of wild-type mice, but we did not find any
rosettes in peritoneal cells of the TNF–/–, GM-CSF–/– or
SCID mice. We also studied PCA reactions using anti-
DNP IgG1 antibody because anti-DNP IgG1 antibody
can induce a PCA reaction via FcγRIII in BALB/c mice.24
The wild-type mice could be sensitized with IgG1 anti-
body to produce anaphylactic reactions, like BALB/c
mice; however, the PCA reaction of both TNF–/– and
GM-CSF–/– mice was compromised. We could not induce
rosette formation with IgG1-coated DNP-SE in deficient
mouse and also in wild-type mice because the affinity of
FcγRIII and FcγRIIB is very low. Further studies are needed
to establish the expression of the low-affinity FcγRIII and
FcγRIIB on mast cells of these deficient mouse strains, but
there is a possibility that FcγRIIB expression may be
depressed and/or FcγRIIB expression may be increased in
TNF–/– and GM-CSF–/– mice.
In other experiments, we examined peritoneal mast
cells from wild type, TNF–/– or GM-CSF–/– mice with
FITC-labeled SPE-7, a murine monoclonal IgE antibody,
for the detection of FcεRI on peritoneal mast cells using
FACScan. For the FACScan experiments, peritoneal mast
cells were incubated with FITC-labeled SPE-7. As shown
in Fig. 2, the image of the control cells from wild-type
mice (Fig. 2a) was displaced to the right, whereas cells
from both the TNF–/– (Fig. 2b) and GM-CSF–/– (Fig. 2c)
were the same and both were shifted to the left relative
to control.
The importance of mast cells in biological reactions,
as versatile effector cells, was reviewed recently.21 Two
extensive reviews of Fc receptors, including those on
mast cells, were recently published.22,23 Moreover, it
has been shown recently that mice genetically man-
ipulated to have no genes for IgE production and,
therefore, deprived of IgE antibody, can still produce
general and also cutaneous anaphylactic reactions.18
This fact is not unexpected, because it has been known
that mice can be sensitized to produce anaphylactic
reactions, not only by IgE, but also by IgG123 and, less
effectively, by IgG2, but not by IgM or IgA antibodies.10
In this respect, it is interesting to note that it was 
the study of guinea pig antibodies25–28 that led to the
understanding that different IgG molecules exist (i.e.
IgG1, IgG2 etc.). Each IgG differs from other IgG by its
Fc fragment and the Fc fragment carries the biological
activities, as first shown in 1961.20,29 Recently, it has
also been shown that the expression of FCεRI on mast
cells may be amplified by the IgE molecule. Decreased
expression of FcεRI often coexists with compromised
expression of IgE antibody, so that FcεRI on mast cells
in IgE–/– mice is 81% less than in IgE+/+ mice.30,31 Our
finding that TNF–/– and GM-CSF–/– mice have a paral-
lel depression in IgE production and FcεRI expression is
consistent with these previous observations. Taken
together, our results indicate a central regulatory role
for TNF and GM-CSF in the expression of critical mast
cell functions.
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